Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Return on Assets (2016 - 2025)

Historic Return on Assets for Marker Therapeutics (MRKR) over the last 11 years, with Q3 2025 value amounting to 0.79%.

  • Marker Therapeutics' Return on Assets fell 1700.0% to 0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.55% for FY2024, which is 7700.0% down from last year.
  • Marker Therapeutics' Return on Assets amounted to 0.79% in Q3 2025, which was down 1700.0% from 0.92% recorded in Q2 2025.
  • In the past 5 years, Marker Therapeutics' Return on Assets ranged from a high of 0.32% in Q4 2023 and a low of 0.92% during Q2 2025
  • In the last 5 years, Marker Therapeutics' Return on Assets had a median value of 0.29% in 2022 and averaged 0.28%.
  • In the last 5 years, Marker Therapeutics' Return on Assets soared by 7400bps in 2023 and then tumbled by -9700bps in 2024.
  • Marker Therapeutics' Return on Assets (Quarter) stood at 0.11% in 2021, then crashed by -275bps to 0.42% in 2022, then skyrocketed by 176bps to 0.32% in 2023, then tumbled by -304bps to 0.65% in 2024, then dropped by -21bps to 0.79% in 2025.
  • Its last three reported values are 0.79% in Q3 2025, 0.92% for Q2 2025, and 0.65% during Q1 2025.